Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Leukemia
|
April 1, 1995
bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis
P Lepelley, V Soenen, C Preudhomme, et al.
Leukemia
|
June 1, 1994
Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes
P Lepelley, V Soenen, C Preudhomme, et al.
Blood
|
February 3, 1998
17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ
V Soenen, C Preudhomme, C Roumier, et al.
Genes, Chromosomes & Cancer
|
May 29, 2000
MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)
M Chaffanet, L Gressin, C Preudhomme, et al.
Leukemia
|
November 1, 1993
Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes
C Preudhomme, P Lepelley, A Vachee, et al.
Haematologica
|
June 28, 2000
Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases
N Cambier, V Soenen-Cornu, J L Laï, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1993
[Decrease of fecal beta-galactosidase activity in Crohn disease]
V Canva-Delcambre, V Soenen, C Mizon, et al.
Leukemia
|
February 13, 2004
A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation
S Depil, P Lepelley, V Soenen, et al.
British Journal of Haematology
|
July 1, 1995
Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes
V Soenen, P Fenaux, M Flactif, et al.
Leukemia
|
March 31, 1998
Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells
V Soenen, C Preudhomme, C Roumier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Leukemia
|
April 1, 1995
bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis
P Lepelley, V Soenen, C Preudhomme, et al.
Leukemia
|
June 1, 1994
Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes
P Lepelley, V Soenen, C Preudhomme, et al.
Blood
|
February 3, 1998
17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ
V Soenen, C Preudhomme, C Roumier, et al.
Genes, Chromosomes & Cancer
|
May 29, 2000
MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)
M Chaffanet, L Gressin, C Preudhomme, et al.
Leukemia
|
November 1, 1993
Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes
C Preudhomme, P Lepelley, A Vachee, et al.
Haematologica
|
June 28, 2000
Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases
N Cambier, V Soenen-Cornu, J L Laï, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1993
[Decrease of fecal beta-galactosidase activity in Crohn disease]
V Canva-Delcambre, V Soenen, C Mizon, et al.
Leukemia
|
February 13, 2004
A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation
S Depil, P Lepelley, V Soenen, et al.
British Journal of Haematology
|
July 1, 1995
Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes
V Soenen, P Fenaux, M Flactif, et al.
Leukemia
|
March 31, 1998
Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells
V Soenen, C Preudhomme, C Roumier, et al.
Page
of 2